Fundraising Fox

Cornucopian Capital Management

Venture capital

Montclair · Pre-Seed–Series A

Fox Verdict
Sign up to see your fit

Investment thesis

Cornucopian Capital deploys long-term capital to build and back results-oriented, high-integrity companies working to make improved healthspan, enhanced performance, and extended longevity accessible to everyone. The firm frames its focus as 'Medicine 3.0,' supporting early-stage ventures that apply scientific knowledge and accessible technologies to deliver health products and services to consumers, patients, and healthcare providers. It emphasizes adding value through its capabilities, strategic partnerships, institutional networks, and collaborators.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Series A
HQ
Montclair, NJ, US
Instruments
Equity
Last 12 months
2 investments
Tracked investments
14

What they invest in

from 12 of 14 portfolio companies

Biotech ×7Deep Tech ×6Healthtech ×5AI & Machine Learning ×3Digital Health ×3FoodTech ×3Longevity ×3AgTech ×1

HQs:United States×6

Investments · 14 tracked

founders shown can be your intro path

By year:2026 · 22022 · 12019 · 14 dated

Archonarchon.bio

Archon Biosciences develops a computational protein design platform leveraging AI and deep learning for therapeutic and vaccine applications.

AI & Machine LearningBiotechDeep TechSeattle, US

George Ueda, Ph.D.(Chief Technology Officer, Co-Founder)James Lazarovits, Ph.D.(Chief Executive Officer, Co-Founder)

Co-investorsMadrona Venture GroupGaorong CapitalGaorong VenturesGobi PartnersIDG CapitalY Combinator+1 more

Barnstormfoundrybarnstormfoundry.com

Barnstorm Foundry is a venture studio focused on building and launching life sciences and biotech companies, drawing on advisors in talent acquisition, commercialization, IP, corporate law, and biosensor technology.

BiotechDeep TechHealthtech

Biocanicbiocanic.com

San Diego, US

Jeremy Malecha(Executive Officer = CEO Director)

BoardPhillip Potter(Director)Giovanni Battistini(Director)

Caffreecaffree.comMar 2026

Caffree develops a powdered enzymatic system for precision decaffeination that converts caffeine into theobromine, allowing coffee brands to control caffeine levels without changing flavor.

BiotechDeep TechFoodTechSeattle, US

Eric Steven Quick(Executive Officer, Director)Aryeh Ganz(Executive Officer, Director, Promoter)

BoardFrank Curzio(Director)

Co-investorsBaruch Future Ventures

Deciduous Therapeuticsdeciduoustx.comJun 2019

Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.

BiotechDigital HealthLongevitySan Francisco, US

Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in

BoardDylan Morris(Director)in

Co-investorsage1Bold Capital PartnersCRV (Charles River Ventures)Owl CapitalquadraScope Venture FundAxial VC

Excelsior Sciencesexcelsiorsci.comin

Excelsior Sciences develops automated chemistry technology for small-molecule discovery and manufacturing, targeting pharmaceutical and materials development.

AI & Machine LearningBiotechDeep Tech

Marty BurkeBartosz GrzybowskiMichael Foley(CEO)Jana Jensen(COO)

Co-investorsKhosla VenturesSofinnova PartnersIllinois Ventures

Handspring Healthhandspringhealth.com

Handspring provides virtual, evidence-based mental health therapy for children, teens, and young adults, primarily using cognitive behavioral therapy along with medication management and parent training.

Digital HealthHealthtechMental Health

Co-investors25MadisonCobalt VenturesNextView VenturesNVP CapitalRPS VenturesVamosVentures+2 more

Ilant HealthinMar 2026

Claymont, US

Elina Onitskansky(Executive Officer, Director, Promoter)

BoardAryeh Ganz(Director)Matthew Klitus(Director)

Co-investorsCity LightLifeX VenturesPeakBridge VC

Insidetrackerinsidetracker.comin𝕏

InsideTracker provides personalized insights into blood work and biomarker analysis to help individuals optimize their health and longevity.

ConsumerHealthtechLongevity

Co-investorsPeakBridge VC

NOVOSnovoslabs.comin𝕏

NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms.

BiotechDirect to ConsumerHealthtechLongevityWellness & Fitness

Chris Mirabile(Founder & CEO)

Co-investorsFab Co-Creation Studio VenturesResolute VenturesRemagine VenturesUNCOMMON DENOMINATOR

Persperiontechpersperiontech.com

Persperion Diagnostics develops touch-based sweat sensing technology for diagnostic measurement.

Deep TechDigital HealthMedical Devices

Co-investors7G BioVenturesFoothill VenturesSamsung Next

Phenotapphenotap.com

PhenoTap develops KetoTap Core, a patent-pending BHB oxidase enzyme designed for reliable, affordable, real-time ketone measurement in blood test strips and continuous monitors.

BiotechDeep TechHealthtech

Giovanni Battistini(CEO & Co-Founder)Janet Tamada(VP of Biosensing & Co-Founder)Joe Wang(Chief Biosensing Scientist & Co-Founder)Ray Garcia(CTO)

Tastewisetastewise.ioin𝕏

Tastewise is an AI-powered consumer intelligence platform for food and beverage brands, turning consumer, menu, and social data into insights for product innovation, marketing, and sales.

AI & Machine LearningData & InfrastructureFoodTech

Co-investorsDisruptive AIPeakBridge VC

Zero Acre Farmszeroacre.cominJul 2022

Zero Acre Farms produces cooking oils optimized for chefs and restaurants, using organic fera fruit oil as an alternative to seed oils with superior heat stability, cleaner taste, and healthier fat profiles.

AgTechFoodTechImpact & Social GoodSan Francisco, US

Jeff Nobbs(Founder & CEO)in

Co-investorsCollaborative FundDesigner FundFifty YearsHabitat PartnersHyperguapJuniper+7 more

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Cornucopian Capital Management made?
Cornucopian Capital Management has 14 tracked investments, including 2 dated in the last 24 months.
What stage does Cornucopian Capital Management invest at?
Cornucopian Capital Management invests at the Pre-Seed, Seed, Series A stages.
What sectors does Cornucopian Capital Management focus on?
Cornucopian Capital Management focuses on Biotech, Consumer, Digital Health, FoodTech, Healthtech, Longevity, Medical Devices, Wellness & Fitness.
Where is Cornucopian Capital Management located?
Cornucopian Capital Management is headquartered in Montclair, US.
Who does Cornucopian Capital Management co-invest with?
Cornucopian Capital Management most often shares deals with PeakBridge VC, Collaborative Fund, CRV (Charles River Ventures), among 34 tracked co-investors.

Similar investors

Featured in lists